PSMA-PET/CT-based salvage elective nodal radiotherapy for lymph node recurrence following radical prostatectomy

• by Samuel M. Vorbach, Hannah Rittmayer, Thomas Seppi, Bernhard Nilica, Mona Kafka, Ute Ganswindt

• September 24, 2025

Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy

• by Severin Rodler, Dina Danninger, Lennert Eismann, Philipp Maximilian Kazmierczak, Friedrich Jokisch, Minglun Li, Armin Becker, Alexander Kretschmer, Christian Stief, Thilo Westhofen

• April 18, 2024

Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer

• by Wolfgang Lilleby, Amar Kishan, Hans Geinitz

• January 20, 2024

Prostate Cancer Conference Highlights from ASCO GU 2025

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from GU ASCO 2025. This video highlights updates in mCRPC and oligometastatic prostate cancer trials.

• March 3, 2025

• 1 min